Women’s Health Diagnostics Market Size, Share, Forecast | Industry Forecast


Posted July 5, 2019 by healthcaremarket

The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period.

 
The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period.

Factors such as growing awareness about various health-related disorders among women, rising incidence of various chronic and lifestyle disorders in women, and high prevalence of infectious diseases such as HIV and hepatitis in women across the globe are driving the growth of the market. Moreover, the increasing adoption of point-of-care diagnostic testing and the increasing number of diagnostic and imaging centres are also expected to play a major role in market growth.

However, shortage of skilled laboratory technicians and high costs of diagnostics devices, tests, and procedures are hindering the growth of women health diagnostics market.

Download PDF Brochure https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128928901

Women’s health diagnostics market segmentation:

• Basis of application
• Basis of end user
• Basis of region

The Major Players Opearting in the Women’s health diagnostics market:

Major players in the global women’s health diagnostics market are Siemens AG (Germany), Quest Diagnostics Inc. (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), PerkinElmer Inc. (U.S.), Alere Inc. (U.S.), GE Healthcare (U.S.), Becton, Dickinson and Company (BD) (U.S.), Abbott Laboratories (U.S.), bioMérieux SA (France), and Koninklijke Philips N.V. (Netherlands).

The Major Players Opearting in the Women’s health diagnostics market:

The global market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America commanded the largest share of the global women health diagnostics market. The major share of this region can be attributed to increasing prevalence of cancer among women in this region, increasing incidence of lifestyle related health disorders, growing focus of manufacturers of women’s health diagnostic products on expanding their presence in this region, and increasing demand for fertility testing monitors.

Read More in Detailed (Women’s health diagnostics market): https://www.marketsandmarkets.com/PressReleases/womens-health-diagnostics.asp
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By markets and markets
Country United States
Categories Health
Tags womens health diagnostics market
Last Updated July 5, 2019